BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 37 filers reported holding BIND THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $294,000 | -3.9% | 133,535 | 0.0% | 0.06% | +26.1% |
| Q4 2015 | $306,000 | -48.7% | 133,535 | 0.0% | 0.05% | -51.6% |
| Q3 2015 | $596,000 | -20.1% | 133,535 | 0.0% | 0.10% | +5.6% |
| Q2 2015 | $746,000 | +1.8% | 133,535 | 0.0% | 0.09% | -27.4% |
| Q1 2015 | $733,000 | +1.7% | 133,535 | 0.0% | 0.12% | -40.7% |
| Q4 2014 | $721,000 | -22.6% | 133,535 | +23.0% | 0.21% | -23.4% |
| Q3 2014 | $932,000 | -34.8% | 108,535 | 0.0% | 0.27% | -35.6% |
| Q2 2014 | $1,430,000 | +99.2% | 108,535 | +80.9% | 0.42% | +96.3% |
| Q1 2014 | $718,000 | – | 60,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 2,018,253 | $9,001,000 | 6.13% |
| FNY Managed Accounts LLC | 30,000 | $133,800,000 | 0.37% |
| Rhenman & Partners Asset Management AB | 133,535 | $596,000 | 0.10% |
| THOMPSON DAVIS & CO., INC. | 4,500 | $20,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 26,000 | $116,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,593 | $373,000 | 0.01% |
| VANGUARD GROUP INC | 5,488,396 | $177,885,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,786 | $512,000 | 0.01% |
| Renaissance Technologies | 269,300 | $1,201,000 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 324,900 | $1,449,000 | 0.00% |